⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TELO News
Telomir Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
TELO
Form 8-K
sec.gov
TELO
Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefits in Wilson's Disease
accessnewswire.com
TELO
Form 8-K
sec.gov
TELO
Telomir Pharmaceuticals Announces FDA Clearance of IND for Telomir-Zn in Triple-Negative Breast Cancer
accessnewswire.com
TELO
Form 8-K
sec.gov
TELO
Telomir Pharmaceuticals Completes Acquisition of TELI Pharmaceuticals, Securing Global Rights to Telomir-1 (Telomir-Zn)
accessnewswire.com
TELO
Form 8-K
sec.gov
TELO
Telomir Pharmaceuticals Submits IND to FDA for Telomir-1 (Telomir-Zn) in Advanced and Metastatic Triple-Negative Breast Cancer
accessnewswire.com
TELO
Telo Genomics Announces Appointment of John Farlinger as CEO and Chairman Ready to Announce with Confidence?
newsfilecorp.com
TELO